Privia Health Group, Inc. (NASDAQ:PRVA) Given Average Rating of “Buy” by Analysts

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have received an average rating of “Buy” from the eighteen ratings firms that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating on the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $24.88.

PRVA has been the topic of several recent analyst reports. Stephens reiterated an “overweight” rating and issued a $26.00 price target on shares of Privia Health Group in a report on Thursday, January 2nd. Macquarie began coverage on Privia Health Group in a research report on Monday, December 16th. They set an “outperform” rating and a $25.00 target price for the company. KeyCorp initiated coverage on shares of Privia Health Group in a research note on Friday, October 11th. They set an “overweight” rating and a $23.00 target price for the company. Needham & Company LLC initiated coverage on shares of Privia Health Group in a research note on Friday. They issued a “buy” rating and a $25.00 price target on the stock. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th.

Privia Health Group Price Performance

Privia Health Group stock opened at $20.51 on Wednesday. Privia Health Group has a 1-year low of $15.92 and a 1-year high of $23.24. The company’s 50-day moving average is $20.93 and its 200 day moving average is $19.47. The firm has a market capitalization of $2.46 billion, a P/E ratio of 205.12, a price-to-earnings-growth ratio of 5.45 and a beta of 0.85.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Canada Pension Plan Investment Board purchased a new stake in shares of Privia Health Group during the 2nd quarter worth $26,000. GAMMA Investing LLC raised its holdings in Privia Health Group by 98.7% in the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock worth $31,000 after purchasing an additional 845 shares in the last quarter. Quarry LP lifted its position in shares of Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after buying an additional 2,533 shares during the last quarter. KBC Group NV boosted its holdings in shares of Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after buying an additional 871 shares in the last quarter. Finally, Neo Ivy Capital Management purchased a new position in shares of Privia Health Group in the 3rd quarter worth approximately $66,000. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.